Related Experiment Video
Updated: Jun 5, 2026

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
Oncogenic mutations of ALK in neuroblastoma
Seishi Ogawa1, Junko Takita, Masashi Sanada
1Cancer Genomics Project, The University of Tokyo, Tokyo, Japan. sogawa-tky@umin.ac.jp
Abstract:
Neuroblastoma is one of the most common solid cancers among children. Prognosis of advanced neuroblastoma is still poor despite the recent advances in chemo/radiotherapies. In view of improving the clinical outcome of advanced neuroblastoma, it is important to identify the key molecules responsible for the pathogenesis of neuroblastoma and to develop effective drugs that target these molecules. Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase, initially identified through the analysis of a specific translocation associated with a rare subtype of non-Hodgkin's lymphoma. Recently it was demonstrated that ALK is frequently mutated in sporadic cases with advanced neuroblastoma. Moreover, germline mutations of ALK were shown to be responsible for the majority of hereditary neuroblastoma. ALK mutants found in neuroblastoma show constitutive active kinase activity and oncogenic potentials. Inhibition of ALK in neuroblastoma cell lines carrying amplified or mutated ALK alleles results in compromised downstream signaling and cell growth, indicating potential roles of small molecule ALK inhibitors in the therapeutics of neuroblastoma carrying mutated ALK kinases.
Insights
Anaplastic lymphoma kinase (ALK) mutations drive advanced neuroblastoma, a common childhood cancer. Targeting these ALK mutations with inhibitors offers a promising therapeutic strategy for improving patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Neuroblastoma is a prevalent pediatric solid cancer with a poor prognosis for advanced stages.
- Current chemo/radiotherapies have limited efficacy in improving outcomes for advanced neuroblastoma.
- Identifying key pathogenic molecules is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of Anaplastic Lymphoma Kinase (ALK) in neuroblastoma pathogenesis.
- To evaluate the therapeutic potential of targeting ALK in neuroblastoma.
Main Methods:
- Analysis of ALK mutations in sporadic and hereditary neuroblastoma cases.
- Assessment of ALK mutant activity and oncogenic potential.
- Inhibition of ALK in neuroblastoma cell lines with mutated or amplified ALK alleles.
Main Results:
- Anaplastic Lymphoma Kinase (ALK) is frequently mutated in sporadic and hereditary neuroblastoma.
- ALK mutations lead to constitutive kinase activity and oncogenic potential.
- Inhibiting ALK compromises downstream signaling and reduces cell growth in neuroblastoma cell lines.
Conclusions:
- Mutated or amplified ALK is a key driver in a significant subset of neuroblastoma.
- Small molecule ALK inhibitors demonstrate therapeutic potential for neuroblastoma patients with ALK alterations.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell

